Scientific Advisory Board

The Scientific Advisory Board serves in an advisory capacity, evaluating the scientific merit of Huntsman Cancer Institute's research programs and their standing in the national and international scientific communities. The board also evaluates the quality of clinical and translational programs and the overall direction of the institute.

	Elizabeth H. Blackburn, PhD Professor, Biochemistry and Biophysics Department University of California, San Francisco San Francisco, California
	Bernard Levin, MD Vice President for Cancer Prevention MD Anderson Cancer Center
	Rae Ann Paden Associate Director, Research Administration University of New Mexico Cancer Center Albuquerque, New Mexico
	Ajit Varki, MD Professor of Medicine and Director, Glycobiology Research and Training Center, University of California, San Diego
	Max S. Wicha, MD Professor of Internal Medicine Director, University of Michigan Comprehensive Cancer Center
	Robert C. Young, MD Chancellor, Fox Chase Cancer Center Philadelphia, Pennsylvania

Past Members

Alfred G. Gilman, MD, PhD, Nobel Laureate

Raymond and Ellen Willies Distinguished
Chair in Molecular Neuropharmacology
Regental Professor and Chairman, Department of Pharmacology
The University of Texas Southwestern Medical Center at Dallas

Bernadine Healy, MD

Former President and Chief Executive Officer
American Red Cross

Stanley J. Korsmeyer, MD

Sidney Farber Professor of Pathology and Professor of Medicine
Dana-Farber Cancer Institute
Investigator, Howard Hughes Medical Institute, Harvard Medical School

Arnold J. Levine, MD

President and Robert and Harriet Heilbrunn Professor
Rockefeller University

Saul A. Rosenberg, MD

Maureen Lyles D'Ambrogio Professor of Medicine and Radiation Oncology, Emeritus
Stanford University School of Medicine
Stanford, California

Phillip A. Sharp, PhD, Nobel Laureate

Salvadore E. Luria Professor of Biology
MIT Institute Professor
Massachusetts Institute of Technology Center for Cancer Research